NanoViricides Inc.

NanoViricides Inc.
Stock Exchange NYSE
EPS
$0.11
Market Cap
$18.42 M
Shares Outstanding
76.74 M
Public Float
47.23 M

Profile

Address
1 Controls Drive
Shelton Connecticut 06484
United States
Employees -
Website http://www.nanoviricides.com
Updated 07/08/2019
NanoViricides, Inc. is a nano-biopharmaceutical company. The company engages in the discovery, development, and commercialization of therapeutics to advance the care of patients suffering from life-threatening viral infections. It intends to manufacture Injectable and Oral FluCide, HIVCide, Nanoviricide Eye Drops, HerpeCide, DengueCide, RabiCide as well as other drugs for pre-clinical animal studies and human clinical studies.

Financials

View All
Created with Highcharts 5.0.14NanoViricides Inc.Net Income. Fiscal year is July-June. All values USD Thousands.8 8758 87513 60113 6012 1982 19810 72410 72410 30410 3048 5638 56320132014201520162017201802.5k5k7.5k10k12.5k15k

Anil R. Diwan
Chairman & President
Stanley Glick
Independent Director